A BC-based tech company in the healthcare industry completed its Series 1 Class Seed Preferred share financing for aggregate consideration of approximately C$250,000. The securities were purchased by the venture arm of a public company with a focus on healthcare technology.
Fasken advised the tech company with a team led by Jon Conlin (Emerging Technology & Venture Capital) and included Brandon Deans and Camille Malone (Emerging Technology & Venture Capital).
Fasken advised the tech company with a team led by Jon Conlin (Emerging Technology & Venture Capital) and included Brandon Deans and Camille Malone (Emerging Technology & Venture Capital).
Jurisdiction
- British Columbia
